Here are four stocks with buy rank and strong value characteristics for investors to consider today, February 13th:
Jabil Inc. (JBL - Free Report) : This electronic manufacturing services and solutions provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1% over the last 60 days.
Jabil has a price-to-earnings ratio (P/E) of 9.34, compared with 17.90 for the industry. The company possesses a Value Score of B.
LexinFintech Holdings Ltd. (LX - Free Report) : This online consumer finance platform has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.
LexinFintech has a price-to-earnings ratio (P/E) of 7.09, compared with 8.40 for the industry. The company possesses a Value Score of B.
Ardagh Group S.A. : This rigid packaging solutions manufacturer for the food and beverage markets has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.
Ardagh has a price-to-earnings ratio (P/E) of 7.10, compared with 17.20 for the industry. The company possesses a Value Score of A.
SkyWest, Inc. (SKYW): This regional airline has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.3% over the last 60 days.
SkyWest has a price-to-earnings ratio (P/E) of 9.48, compared with 14.20 for the industry. The company possesses a Value Scoreof A.
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong value characteristics for investors to consider today, February 13th:
Jabil Inc. (JBL - Free Report) : This electronic manufacturing services and solutions provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1% over the last 60 days.
Jabil has a price-to-earnings ratio (P/E) of 9.34, compared with 17.90 for the industry. The company possesses a Value Score of B.
LexinFintech Holdings Ltd. (LX - Free Report) : This online consumer finance platform has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.
LexinFintech has a price-to-earnings ratio (P/E) of 7.09, compared with 8.40 for the industry. The company possesses a Value Score of B.
Ardagh Group S.A. : This rigid packaging solutions manufacturer for the food and beverage markets has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.
Ardagh has a price-to-earnings ratio (P/E) of 7.10, compared with 17.20 for the industry. The company possesses a Value Score of A.
SkyWest, Inc. (SKYW): This regional airline has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.3% over the last 60 days.
SkyWest has a price-to-earnings ratio (P/E) of 9.48, compared with 14.20 for the industry. The company possesses a Value Scoreof A.
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on JBL - FREE
Get the latest research report on BTI - FREE
Get the latest research report on LX - FREE